Abstract:453 Background: Endogenous retroviruses (ERVs) represent 5-8% of the human genome, and their expression in cancer cells correlates with response to immunotherapy in clear cell renal cell carcinoma (ccRCC). Whether this association also exists in papillary renal cell carcinoma (PRCC) is unknown. Studying ERV expression in PRCC and its impact on the tumor microenvironment (TME) may help elucidate its role in PRCC response to immunotherapy. Methods: We quantified ERV expression on human PRCC tissue samples using real-time quantitative PCR (RT-qPCR). ERV4700 was selected due its correlation with response to immunotherapy when expressed in ccRCC. In addition, we stained matched human FFPE tissue with 31 antibodies using multiplex immunohistochemistry (mxIHC) to investigate the TME. Using mxIHC protein expression levels, we generated a probabilistic cell classification algorithm to quantify immune cells. We investigated associations between ERV expression data, clinicopathologic variables, and immune cell proportions in the tumor samples using linear regression. Results: We performed ERV expression and mxIHC analysis on 104 PRCC nephrectomy samples from 1997-2016. After quality control, 78 unique patient tumor samples had results from both pipelines. Median patient age was 65 (IQR 56-71), 74.4% were male, and Fuhrman grade was 1 in 3.9%, 2 in 5.9%, 3 in 50.0%, and 4 in 9.0% of patients. Over a median follow-up of 3.03 years (IQR 0.61-6.99 years), 11.5% had recurrence after definitive local therapy, and 7.7% had an RCC-related death. Increased ERV expression correlated with increasing Fuhrman grade (r = 0.057, p <0.001), but not with disease recurrence or RCC-related death. Increased ERV expression was also associated with an increased TME proportion of cytotoxic T cells, memory T cells, and CD20+ B cells, and with a decreased TME proportion of macrophages (see Table 1). Conclusions: Higher expression of ERV4700 correlates with increased proportions of cytotoxic T cells in the TME of PRCC samples. Given its association with immunotherapy response in ccRCC, further studies are warranted to study ERV expression as a prognostic and predictive biomarker in PRCC. [Table: see text]

Endogenous retrovirus expression and its impact on tumor-infiltrating immune cells in papillary renal cell carcinoma.